- Who can participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months are eligible. Participants should not have any other severe medical conditions or be currently participating in another clinical trial.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular assessments of pain levels and quality of life through questionnaires and physical examinations.

